Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · IEX Real-Time Price · USD
3.850
+0.085 (2.26%)
Jul 22, 2024, 11:28 AM EDT - Market open
Sutro Biopharma Employees
Sutro Biopharma had 302 employees as of December 31, 2023. The number of employees increased by 24 or 8.63% compared to the previous year.
Employees
302
Change (1Y)
24
Growth (1Y)
8.63%
Revenue / Employee
$510,149
Profits / Employee
-$380,649
Market Cap
307.55M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
DocGo | 4,164 |
Aurora Cannabis | 1,073 |
OraSure Technologies | 638 |
MacroGenics | 339 |
Pulmonx | 279 |
Nyxoah | 147 |
Enanta Pharmaceuticals | 145 |
Atea Pharmaceuticals | 75 |
STRO News
- 7 weeks ago - VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipeline - PRNewsWire
- 2 months ago - Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones - GlobeNewsWire
- 2 months ago - Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRαME-O1 Trial - GlobeNewsWire
- 3 months ago - Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering - GlobeNewsWire
- 3 months ago - Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors - GlobeNewsWire
- 4 months ago - Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones - GlobeNewsWire
- 5 months ago - Sutro Biopharma to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 months ago - Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC - GlobeNewsWire